PRELP has prognostic value and regulates cell proliferation and migration in hepatocellular carcinoma

Runqi Hong(Fudan University), Chongwei Ke(Fudan University), Gengming Niu(Institute for Biomedicine), Xiaotian Zhang(Peking University), Tao Song(Central South University), Jiawei Gu(Fudan University), Zhiqing Hu(Central South University), Liang Hong(Henan University), Shanliang Han(Fudan University)

Journal of Cancer

January 1, 2020

10.7150/jca.46309

Cited by 33

Related Papers

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

|The Lancet Oncology|2021|436

Single‐cell landscape and clinical outcomes of infiltrating B cells in colorectal cancer

|Immunology|2022|136

<i>In vivo</i> MR and Fluorescence Dual-modality Imaging of Atherosclerosis Characteristics in Mice Using Profilin-1 Targeted Magnetic Nanoparticles

|Theranostics|2015|110

Expression of miR-143 reduces growth and migration of human bladder carcinoma cells by targeting cyclooxygenase-2.

|PubMed|2011|44

GABRD promotes progression and predicts poor prognosis in colorectal cancer

|Open Medicine|2020|42